{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T15:32:55Z","timestamp":1791646375969,"version":"4.3.4"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,24]],"date-time":"2025-07-24T00:00:00Z","timestamp":1753315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,24]],"date-time":"2025-07-24T00:00:00Z","timestamp":1753315200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Medical Scienceand Technology Project of Zhejiang Province","award":["2023KY516"],"award-info":[{"award-number":["2023KY516"]}]},{"name":"Zhejiang Traditional Chinese Medicine Scientific Research Fund Project","award":["2023ZL243"],"award-info":[{"award-number":["2023ZL243"]}]},{"name":"Zhejiang Medical and Health Science Technology","award":["2025694526"],"award-info":[{"award-number":["2025694526"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Clin Immunol"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s10875-025-01914-x","type":"journal-article","created":{"date-parts":[[2025,7,24]],"date-time":"2025-07-24T06:29:05Z","timestamp":1753338545000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Dupilumab-induced Eosinophilic Granulomatosis with Polyangiitis Complicated by Peripheral Neuropathic Pain: a Case Report and Literature Review"],"prefix":"10.1007","volume":"45","author":[{"given":"Jiajun","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linlin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weidong","family":"Ten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuchen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruiqi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Binbin","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feilin","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaiwen","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haibo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lizhong","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiming","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,24]]},"reference":[{"issue":"2","key":"1914_CR1","first-page":"277","volume":"27","author":"J Churg","year":"1951","unstructured":"Churg J, Strauss L. Allergic granulomatosis, allergic angiitis, and periarteritis nodosa. Am J Pathol. 1951;27(2):277\u2013301.","journal-title":"Am J Pathol."},{"issue":"1","key":"1914_CR2","doi-asserted-by":"publisher","first-page":"103219","DOI":"10.1016\/j.autrev.2022.103219","volume":"22","author":"J White","year":"2023","unstructured":"White J, Dubey S. Eosinophilic granulomatosis with polyangiitis: A review. Autoimmun Rev. 2023;22(1):103219.","journal-title":"Autoimmun Rev"},{"issue":"10","key":"1914_CR3","doi-asserted-by":"publisher","first-page":"1916","DOI":"10.1093\/rheumatology\/ker205","volume":"50","author":"S Fujimoto","year":"2011","unstructured":"Fujimoto S, Watts RA, Kobayashi S, et al. Comparison of the epidemiology of anti-neutrophil cytoplasmic antibody-associated vasculitis between Japan and the U.K. Rheumatology (Oxford). 2011;50(10):1916\u201320.","journal-title":"Rheumatology (Oxford)."},{"issue":"3","key":"1914_CR4","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1002\/art.11115","volume":"49","author":"MA Gonzalez-Gay","year":"2003","unstructured":"Gonzalez-Gay MA, Garcia-Porrua C, Guerrero J, Rodriguez-Ledo P, Llorca J. The epidemiology of the primary systemic vasculitides in northwest Spain: implications of the Chapel Hill Consensus Conference definitions. Arthritis Rheum. 2003;49(3):388\u201393.","journal-title":"Arthritis Rheum."},{"issue":"1","key":"1914_CR5","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1002\/art.20928","volume":"53","author":"E Reinhold-Keller","year":"2005","unstructured":"Reinhold-Keller E, Herlyn K, Wagner-Bastmeyer R, Gross WL. Stable incidence of primary systemic vasculitides over five years: results from the German vasculitis register. Arthritis Rheum. 2005;53(1):93\u20139.","journal-title":"Arthritis Rheum"},{"issue":"12","key":"1914_CR6","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1093\/rheumatology\/kep304","volume":"48","author":"AJ Mohammad","year":"2009","unstructured":"Mohammad AJ, Jacobsson LT, Westman KW, Sturfelt G, Segelmark M. Incidence and survival rates in wegener\u2019s granulomatosis, microscopic polyangiitis, Churg-Strauss syndrome and polyarteritis nodosa. Rheumatology (Oxford). 2009;48(12):1560\u20135.","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"1914_CR7","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1002\/1529-0131(200002)43:2<414::AID-ANR23>3.0.CO;2-0","volume":"43","author":"RA Watts","year":"2000","unstructured":"Watts RA, Lane SE, Bentham G, Scott DG. Epidemiology of systemic vasculitis: a ten-year study in the united Kingdom. Arthritis Rheum. 2000;43(2):414\u20139.","journal-title":"Arthritis Rheum"},{"issue":"3","key":"1914_CR8","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1002\/(SICI)1099-1557(199905\/06)8:3<179::AID-PDS414>3.0.CO;2-K","volume":"8","author":"RM Martin","year":"1999","unstructured":"Martin RM, Wilton LV, Mann RD. Prevalence of Churg-Strauss syndrome, vasculitis, eosinophilia and associated conditions: retrospective analysis of 58 prescription-event monitoring cohort studies. Pharmacoepidemiol Drug Saf. 1999;8(3):179\u201389.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"1","key":"1914_CR9","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1002\/art.20077","volume":"51","author":"A Mahr","year":"2004","unstructured":"Mahr A, Guillevin L, Poissonnet M, Aym\u00e9 S. Prevalences of polyarteritis nodosa, microscopic polyangiitis, wegener\u2019s granulomatosis, and Churg-Strauss syndrome in a French urban multiethnic population in 2000: a capture-recapture estimate. Arthritis Rheum. 2004;51(1):92\u20139.","journal-title":"Arthritis Rheum"},{"issue":"4","key":"1914_CR10","doi-asserted-by":"publisher","first-page":"640","DOI":"10.3109\/14397595.2013.857582","volume":"24","author":"KE Sada","year":"2014","unstructured":"Sada KE, Amano K, Uehara R, et al. A nationwide survey on the epidemiology and clinical features of eosinophilic granulomatosis with polyangiitis (Churg-Strauss) in Japan. Mod Rheumatol. 2014;24(4):640\u20134.","journal-title":"Mod Rheumatol"},{"issue":"1","key":"1914_CR11","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/s41572-020-0204-y","volume":"6","author":"AR Kitching","year":"2020","unstructured":"Kitching AR, Anders HJ, Basu N, et al. ANCA-associated vasculitis. Nat Rev Dis Primers. 2020;6(1):71.","journal-title":"Nat Rev Dis Primers"},{"issue":"3 Suppl 82","key":"1914_CR12","first-page":"S41","volume":"32","author":"BM Sokolowska","year":"2014","unstructured":"Sokolowska BM, Szczeklik WK, Wludarczyk AA, et al. ANCA-positive and ANCA-negative phenotypes of eosinophilic granulomatosis with polyangiitis (EGPA): outcome and long-term follow-up of 50 patients from a single Polish center. Clin Exp Rheumatol. 2014;32(3 Suppl 82):S41\u20137.","journal-title":"Clin Exp Rheumatol"},{"issue":"4","key":"1914_CR13","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/j.alit.2019.06.004","volume":"68","author":"S Furuta","year":"2019","unstructured":"Furuta S, Iwamoto T, Nakajima H. Update on eosinophilic granulomatosis with polyangiitis. Allergol Int. 2019;68(4):430\u20136.","journal-title":"Allergol Int"},{"issue":"1","key":"1914_CR14","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1002\/art.37721","volume":"65","author":"C Comarmond","year":"2013","unstructured":"Comarmond C, Pagnoux C, Khellaf M, et al. Eosinophilic granulomatosis with polyangiitis (Churg-Strauss): clinical characteristics and long-term followup of the 383 patients enrolled in the French vasculitis study group cohort. Arthritis Rheum. 2013;65(1):270\u201381.","journal-title":"Arthritis Rheum"},{"issue":"1","key":"1914_CR15","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1097\/BOR.0b013e3280119854","volume":"19","author":"C Pagnoux","year":"2007","unstructured":"Pagnoux C, Guilpain P, Guillevin L. Churg-Strauss syndrome. Curr Opin Rheumatol. 2007;19(1):25\u201332.","journal-title":"Curr Opin Rheumatol"},{"issue":"6","key":"1914_CR16","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1038\/s41584-023-00958-w","volume":"19","author":"G Emmi","year":"2023","unstructured":"Emmi G, Bettiol A, Gelain E, et al. Evidence-Based guideline for the diagnosis and management of eosinophilic granulomatosis with polyangiitis. Nat Rev Rheumatol. 2023;19(6):378\u201393.","journal-title":"Nat Rev Rheumatol"},{"issue":"3","key":"1914_CR17","doi-asserted-by":"publisher","first-page":"104039","DOI":"10.1016\/j.lpm.2020.104039","volume":"49","author":"G Sacoto","year":"2020","unstructured":"Sacoto G, Boukhlal S, Specks U, Flores-Su\u00e1rez LF, Cornec D. Lung involvement in ANCA-associated vasculitis. Presse Med. 2020;49(3):104039.","journal-title":"Presse Med"},{"issue":"2","key":"1914_CR18","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.jaip.2024.10.013","volume":"13","author":"Y Puan","year":"2025","unstructured":"Puan Y, Ong KY, Tiew PY, et al. Characteristics of severe asthma clinic patients with eosinophilic granulomatosis with polyangiitis. J Allergy Clin Immunol Pract. 2025;13(2):361\u2013e3682.","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"11","key":"1914_CR19","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1007\/s11926-022-01087-1","volume":"24","author":"M Bond","year":"2022","unstructured":"Bond M, Fagni F, Moretti M, et al. At the heart of eosinophilic granulomatosis with polyangiitis: into cardiac and vascular involvement. Curr Rheumatol Rep. 2022;24(11):337\u201351.","journal-title":"Curr Rheumatol Rep"},{"issue":"2","key":"1914_CR20","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1093\/rheumatology\/keae085","volume":"64","author":"X Liu","year":"2025","unstructured":"Liu X, Zhou Y, Li J, et al. Cardiac involvement in eosinophilic granulomatosis with polyangiitis: acute eosinophilic myocarditis and chronic inflammatory cardiomyopathy. Rheumatology (Oxford). 2025;64(2):722\u201331.","journal-title":"Rheumatology (Oxford)"},{"issue":"3","key":"1914_CR21","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1093\/rheumatology\/keab514","volume":"61","author":"S Sartorelli","year":"2022","unstructured":"Sartorelli S, Chassagnon G, Cohen P, et al. Revisiting characteristics, treatment and outcome of cardiomyopathy in eosinophilic granulomatosis with polyangiitis (formerly Churg-Strauss). Rheumatology (Oxford). 2022;61(3):1175\u201384.","journal-title":"Rheumatology (Oxford)"},{"key":"1914_CR22","doi-asserted-by":"publisher","first-page":"1099722","DOI":"10.3389\/fimmu.2022.1099722","volume":"13","author":"R Li","year":"2022","unstructured":"Li R, Chen Y, Zhang S, et al. Clinical characteristics and long-term outcome of patients with Gastrointestinal involvement in eosinophilic granulomatosis with polyangiitis. Front Immunol. 2022;13:1099722.","journal-title":"Front Immunol"},{"issue":"6","key":"1914_CR23","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.3390\/biomedicines10061227","volume":"10","author":"E Niccolai","year":"2022","unstructured":"Niccolai E, Bettiol A, Baldi S, et al. Gut microbiota and associated mucosal immune response in eosinophilic granulomatosis with polyangiitis (EGPA). Biomedicines. 2022;10(6):1227.","journal-title":"Biomedicines"},{"issue":"18","key":"1914_CR24","doi-asserted-by":"publisher","first-page":"5996","DOI":"10.3390\/jcm12185996","volume":"12","author":"R Watanabe","year":"2023","unstructured":"Watanabe R, Hashimoto M. Eosinophilic granulomatosis with polyangiitis: latest findings and updated treatment recommendations. J Clin Med. 2023;12(18):5996.","journal-title":"J Clin Med"},{"issue":"8","key":"1914_CR25","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1007\/s40265-018-0920-8","volume":"78","author":"L Raffray","year":"2018","unstructured":"Raffray L, Guillevin L. Treatment of eosinophilic granulomatosis with polyangiitis: A review. Drugs. 2018;78(8):809\u201321.","journal-title":"Drugs"},{"issue":"2","key":"1914_CR26","doi-asserted-by":"publisher","first-page":"97","DOI":"10.18176\/jiaci.0682","volume":"32","author":"FJ Mu\u00f1oz-Bellido","year":"2022","unstructured":"Mu\u00f1oz-Bellido FJ, Moreno E, D\u00e1vila I, Dupilumab. A review of present indications and Off-Label uses. J Investig Allergol Clin Immunol. 2022;32(2):97\u2013115.","journal-title":"J Investig Allergol Clin Immunol"},{"issue":"10","key":"1914_CR27","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1007\/s40265-017-0768-3","volume":"77","author":"M Shirley","year":"2017","unstructured":"Shirley M, Dupilumab. First global approval. Drugs. 2017;77(10):1115\u201321.","journal-title":"Drugs"},{"issue":"24","key":"1914_CR28","doi-asserted-by":"publisher","first-page":"2335","DOI":"10.1056\/NEJMoa1610020","volume":"375","author":"EL Simpson","year":"2016","unstructured":"Simpson EL, Bieber T, Guttman-Yassky E, et al. Two phase 3 trials of dupilumab versus placebo in atopic dermatitis. N Engl J Med. 2016;375(24):2335\u201348.","journal-title":"N Engl J Med"},{"issue":"3 Suppl 1","key":"1914_CR29","doi-asserted-by":"publisher","first-page":"S28","DOI":"10.1016\/j.jaad.2017.12.022","volume":"78","author":"MJ Gooderham","year":"2018","unstructured":"Gooderham MJ, Hong HC, Eshtiaghi P, Papp KA, Dupilumab. A review of its use in the treatment of atopic dermatitis. J Am Acad Dermatol. 2018;78(3 Suppl 1):S28\u201336.","journal-title":"J Am Acad Dermatol"},{"issue":"26","key":"1914_CR30","doi-asserted-by":"publisher","first-page":"2486","DOI":"10.1056\/NEJMoa1804092","volume":"378","author":"M Castro","year":"2018","unstructured":"Castro M, Corren J, Pavord ID, et al. Dupilumab efficacy and safety in Moderate-to-Severe uncontrolled asthma. N Engl J Med. 2018;378(26):2486\u201396.","journal-title":"N Engl J Med"},{"issue":"10209","key":"1914_CR31","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1016\/S0140-6736(19)31881-1","volume":"394","author":"C Bachert","year":"2019","unstructured":"Bachert C, Han JK, Desrosiers M, et al. Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials. Lancet. 2019;394(10209):1638\u201350.","journal-title":"Lancet"},{"issue":"10","key":"1914_CR32","doi-asserted-by":"publisher","first-page":"2695","DOI":"10.1016\/j.jaip.2022.05.019","volume":"10","author":"ME Wechsler","year":"2022","unstructured":"Wechsler ME, Klion AD, Paggiaro P, et al. Effect of dupilumab on blood eosinophil counts in patients with asthma, chronic rhinosinusitis with nasal polyps, atopic dermatitis, or eosinophilic esophagitis. J Allergy Clin Immunol Pract. 2022;10(10):2695\u2013709.","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"10","key":"1914_CR33","doi-asserted-by":"publisher","first-page":"2710","DOI":"10.1016\/j.jaip.2022.08.006","volume":"10","author":"WW Busse","year":"2022","unstructured":"Busse WW. Dupilumab and eosinophils: A red flag. J Allergy Clin Immunol Pract. 2022;10(10):2710\u20132.","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"3","key":"1914_CR34","doi-asserted-by":"publisher","first-page":"165","DOI":"10.18176\/jiaci.0823","volume":"32","author":"JM Olaguibel","year":"2022","unstructured":"Olaguibel JM, Sastre J, Rodr\u00edguez JM, Del Pozo V. Eosinophilia induced by blocking the IL-4\/IL-13 pathway: potential mechanisms and clinical outcomes. J Investig Allergol Clin Immunol. 2022;32(3):165\u201380.","journal-title":"J Investig Allergol Clin Immunol"},{"issue":"7","key":"1914_CR35","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1080\/17476348.2022.2090342","volume":"16","author":"M Caminati","year":"2022","unstructured":"Caminati M, Olivieri B, Dama A, et al. Dupilumab-induced hypereosinophilia: review of the literature and algorithm proposal for clinical management. Expert Rev Respir Med. 2022;16(7):713\u201321.","journal-title":"Expert Rev Respir Med"},{"issue":"3","key":"1914_CR36","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1136\/annrheumdis-2021-221794","volume":"81","author":"PC Grayson","year":"2022","unstructured":"Grayson PC, Ponte C, Suppiah R, et al. 2022 American college of rheumatology\/european alliance of associations for rheumatology classification criteria for eosinophilic granulomatosis with polyangiitis. Ann Rheum Dis. 2022;81(3):309\u201314.","journal-title":"Ann Rheum Dis"},{"key":"1914_CR37","doi-asserted-by":"publisher","first-page":"1285598","DOI":"10.3389\/fimmu.2024.1285598","volume":"15","author":"S AlBloushi","year":"2024","unstructured":"AlBloushi S, Al-Ahmad M. Exploring the immunopathology of type 2 inflammatory airway diseases. Front Immunol. 2024;15:1285598.","journal-title":"Front Immunol"},{"issue":"2","key":"1914_CR38","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1007\/s12016-014-8444-9","volume":"50","author":"P Sriaroon","year":"2016","unstructured":"Sriaroon P, Ballow M. Biological modulators in eosinophilic diseases. Clin Rev Allergy Immunol. 2016;50(2):252\u201372.","journal-title":"Clin Rev Allergy Immunol"},{"issue":"4","key":"1914_CR39","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1165\/ajrcmb\/8.4.349","volume":"8","author":"MB Resnick","year":"1993","unstructured":"Resnick MB, Weller PF. Mechanisms of eosinophil recruitment. Am J Respir Cell Mol Biol. 1993;8(4):349\u201355.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"1914_CR40","first-page":"178","volume":"92","author":"AJ Wardlaw","year":"1993","unstructured":"Wardlaw AJ. Eosinophil adhesion receptors. Behring Inst Mitt. 1993;92:178\u201383.","journal-title":"Behring Inst Mitt"},{"key":"1914_CR41","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1111\/j.1749-6632.1992.tb39754.x","volume":"664","author":"PF Weller","year":"1992","unstructured":"Weller PF. Intercellular interactions in the recruitment and functions of human eosinophils. Ann N Y Acad Sci. 1992;664:116\u201325.","journal-title":"Ann N Y Acad Sci"},{"issue":"7","key":"1914_CR42","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.ejim.2015.04.022","volume":"26","author":"M Groh","year":"2015","unstructured":"Groh M, Pagnoux C, Baldini C, et al. Eosinophilic granulomatosis with polyangiitis (Churg-Strauss) (EGPA) consensus task force recommendations for evaluation and management. Eur J Intern Med. 2015;26(7):545\u201353.","journal-title":"Eur J Intern Med"},{"issue":"9","key":"1914_CR43","doi-asserted-by":"publisher","first-page":"632","DOI":"10.7326\/0003-4819-143-9-200511010-00006","volume":"143","author":"R Sabl\u00e9-Fourtassou","year":"2005","unstructured":"Sabl\u00e9-Fourtassou R, Cohen P, Mahr A, et al. Antineutrophil cytoplasmic antibodies and the Churg-Strauss syndrome. Ann Intern Med. 2005;143(9):632\u20138.","journal-title":"Ann Intern Med"},{"issue":"9","key":"1914_CR44","doi-asserted-by":"publisher","first-page":"2926","DOI":"10.1002\/art.21250","volume":"52","author":"RA Sinico","year":"2005","unstructured":"Sinico RA, Di Toma L, Maggiore U, et al. Prevalence and clinical significance of antineutrophil cytoplasmic antibodies in Churg-Strauss syndrome. Arthritis Rheum. 2005;52(9):2926\u201335.","journal-title":"Arthritis Rheum"},{"issue":"12","key":"1914_CR45","doi-asserted-by":"publisher","first-page":"3157","DOI":"10.1007\/s00330-007-0700-4","volume":"17","author":"YK Kim","year":"2007","unstructured":"Kim YK, Lee KS, Chung MP, et al. Pulmonary involvement in Churg-Strauss syndrome: an analysis of CT, clinical, and pathologic findings. Eur Radiol. 2007;17(12):3157\u201365.","journal-title":"Eur Radiol"},{"issue":"5","key":"1914_CR46","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1183\/13993003.00097-2016","volume":"48","author":"V Cottin","year":"2016","unstructured":"Cottin V, Bel E, Bottero P, et al. Respiratory manifestations of eosinophilic granulomatosis with polyangiitis (Churg-Strauss). Eur Respir J. 2016;48(5):1429\u201341.","journal-title":"Eur Respir J"},{"issue":"11","key":"1914_CR47","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1016\/j.autrev.2017.09.009","volume":"16","author":"L Frumholtz","year":"2017","unstructured":"Frumholtz L, Laurent-Roussel S, Auma\u00eetre O, et al. Clinical and pathological significance of cutaneous manifestations in ANCA-associated vasculitides. Autoimmun Rev. 2017;16(11):1138\u201346.","journal-title":"Autoimmun Rev"},{"issue":"1","key":"1914_CR48","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1186\/s13287-024-03924-9","volume":"15","author":"H Wang","year":"2024","unstructured":"Wang H, Zhang Q, Wu S, et al. Mesenchymal stem cell therapy in eosinophilic granulomatosis with polyangiitis-related lower limb gangrene: a case report. Stem Cell Res Ther. 2024;15(1):307.","journal-title":"Stem Cell Res Ther"},{"issue":"2","key":"1914_CR49","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1111\/ijd.16214","volume":"62","author":"H Shakshouk","year":"2023","unstructured":"Shakshouk H, Gibson LE. Cutaneous manifestations of ANCA-associated vasculitis: a retrospective review of 211 cases with emphasis on clinicopathologic correlation and ANCA status. Int J Dermatol. 2023;62(2):231\u20138.","journal-title":"Int J Dermatol"},{"issue":"11","key":"1914_CR50","doi-asserted-by":"publisher","first-page":"E1333","DOI":"10.1055\/a-0977-2777","volume":"7","author":"K Kawasaki","year":"2019","unstructured":"Kawasaki K, Nakamura S, Esaki M, et al. Gastrointestinal involvement in patients with vasculitis: IgA vasculitis and eosinophilic granulomatosis with polyangiitis. Endosc Int Open. 2019;7(11):E1333\u201343.","journal-title":"Endosc Int Open"},{"issue":"2","key":"1914_CR51","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1097\/01.md.0000158825.87055.0b","volume":"84","author":"C Pagnoux","year":"2005","unstructured":"Pagnoux C, Mahr A, Cohen P, Guillevin L. Presentation and outcome of Gastrointestinal involvement in systemic necrotizing vasculitides: analysis of 62 patients with polyarteritis nodosa, microscopic polyangiitis, wegener granulomatosis, Churg-Strauss syndrome, or rheumatoid arthritis-associated vasculitis. Med (Baltim). 2005;84(2):115\u201328.","journal-title":"Med (Baltim)"},{"key":"1914_CR52","doi-asserted-by":"publisher","first-page":"107193","DOI":"10.1016\/j.carpath.2019.107193","volume":"47","author":"Y Ito","year":"2020","unstructured":"Ito Y, Yoshida M, Sugiyama T, et al. Multiple ulcerations and perforation in the small intestine after steroid treatment in eosinophilic granulomatosis with polyangiitis: a case report and literature review. Cardiovasc Pathol. 2020;47:107193.","journal-title":"Cardiovasc Pathol"},{"issue":"4","key":"1914_CR53","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1097\/MD.0b013e3181af35a5","volume":"88","author":"T Neumann","year":"2009","unstructured":"Neumann T, Manger B, Schmid M, et al. Cardiac involvement in Churg-Strauss syndrome: impact of endomyocarditis. Med (Baltim). 2009;88(4):236\u201343.","journal-title":"Med (Baltim)"},{"issue":"1","key":"1914_CR54","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1093\/rheumatology\/keaa416","volume":"60","author":"CA Durel","year":"2021","unstructured":"Durel CA, Sinico RA, Teixeira V, et al. Renal involvement in eosinophilic granulomatosis with polyangiitis (EGPA): a multicentric retrospective study of 63 biopsy-proven cases. Rheumatology (Oxford). 2021;60(1):359\u201365.","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"1914_CR55","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1111\/all.15544","volume":"78","author":"P Valent","year":"2023","unstructured":"Valent P, Klion AD, Roufosse F, et al. Proposed refined diagnostic criteria and classification of eosinophil disorders and related syndromes. Allergy. 2023;78(1):47\u201359.","journal-title":"Allergy"},{"issue":"3","key":"1914_CR56","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1111\/all.12088","volume":"68","author":"A Vaglio","year":"2013","unstructured":"Vaglio A, Buzio C, Zwerina J. Eosinophilic granulomatosis with polyangiitis (Churg-Strauss): state of the Art. Allergy. 2013;68(3):261\u201373.","journal-title":"Allergy"},{"issue":"6","key":"1914_CR57","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1093\/rheumatology\/ken033","volume":"47","author":"K Polzer","year":"2008","unstructured":"Polzer K, Karonitsch T, Neumann T, et al. Eotaxin-3 is involved in Churg-Strauss syndrome\u2013a serum marker closely correlating with disease activity. Rheumatology (Oxford). 2008;47(6):804\u20138.","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"1914_CR58","doi-asserted-by":"crossref","first-page":"125","DOI":"10.2165\/00126839-200809020-00006","volume":"9","author":"Mepolizumab","year":"2008","unstructured":"Mepolizumab. 240563, anti-IL-5 monoclonal antibody - GlaxoSmithKline, anti-interleukin-5 monoclonal antibody - GlaxoSmithKline, SB 240563. Drugs R D. 2008;9(2):125\u201330.","journal-title":"Drugs R D"},{"issue":"12","key":"1914_CR59","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1136\/ard-2023-224756","volume":"82","author":"B Molina","year":"2023","unstructured":"Molina B, Padoan R, Urban ML, et al. Dupilumab for relapsing or refractory sinonasal and\/or asthma manifestations in eosinophilic granulomatosis with polyangiitis: a European retrospective study. Ann Rheum Dis. 2023;82(12):1587\u201393.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"1914_CR60","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s13223-021-00639-x","volume":"18","author":"S Adachi","year":"2022","unstructured":"Adachi S, Oshikata C, Kaneko T, Tsurikisawa N. Rituximab and dupilumab improve eosinophilic granulomatosis with polyangiitis with multiple pulmonary thrombi. Allergy Asthma Clin Immunol. 2022;18(1):18.","journal-title":"Allergy Asthma Clin Immunol"},{"issue":"3","key":"1914_CR61","doi-asserted-by":"publisher","first-page":"e96","DOI":"10.1093\/rheumatology\/kead479","volume":"63","author":"M Caminati","year":"2024","unstructured":"Caminati M, Scarpieri E, Maule M, et al. Successful switching from mepolizumab to dupilumab in a patient with EGPA in remission phase and persistent nasal polyposis. Rheumatology (Oxford). 2024;63(3):e96\u20138.","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"1914_CR62","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1093\/mrcr\/rxad059","volume":"8","author":"Y Iwadate","year":"2023","unstructured":"Iwadate Y, Arinuma Y, Matsueda Y, et al. A case of dupilumab combination therapy for exacerbation of atopic dermatitis in a patient with eosinophilic granulomatosis with polyangiitis treated with mepolizumab. Mod Rheumatol Case Rep. 2023;8(1):159\u201362.","journal-title":"Mod Rheumatol Case Rep"},{"issue":"3","key":"1914_CR63","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.jacig.2022.03.006","volume":"1","author":"K Yamazaki","year":"2022","unstructured":"Yamazaki K, Nomizo T, Hatanaka K, Hayama N, Oguma T, Asano K. Eosinophilic granulomatosis with polyangiitis after treatment with dupilumab. J Allergy Clin Immunol Glob. 2022;1(3):180\u20132.","journal-title":"J Allergy Clin Immunol Glob"},{"issue":"5","key":"1914_CR64","doi-asserted-by":"publisher","first-page":"755","DOI":"10.2169\/internalmedicine.7990-21","volume":"61","author":"M Ikeda","year":"2022","unstructured":"Ikeda M, Ohshima N, Kawashima M, Shiina M, Kitani M, Suzukawa M. Severe asthma where eosinophilic granulomatosis with polyangiitis became apparent after the discontinuation of dupilumab. Intern Med. 2022;61(5):755\u20139.","journal-title":"Intern Med"},{"issue":"5","key":"1914_CR65","first-page":"e25218","volume":"14","author":"S Tanaka","year":"2022","unstructured":"Tanaka S, Tsuji T, Shiotsu S, Yuba T, Hiraoka N. Exacerbation of eosinophilic granulomatosis with polyangiitis after administering dupilumab for severe asthma and eosinophilic rhinosinusitis with nasal polyposis. Cureus. 2022;14(5):e25218.","journal-title":"Cureus"},{"issue":"1","key":"1914_CR66","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1186\/s12890-023-02415-6","volume":"23","author":"I Suzaki","year":"2023","unstructured":"Suzaki I, Tanaka A, Yanai R, et al. Eosinophilic granulomatosis with polyangiitis developed after dupilumab administration in patients with eosinophilic chronic rhinosinusitis and asthma: a case report. BMC Pulm Med. 2023;23(1):130.","journal-title":"BMC Pulm Med"},{"issue":"3","key":"1914_CR67","doi-asserted-by":"publisher","first-page":"e003300","DOI":"10.1136\/rmdopen-2023-003300","volume":"9","author":"M Kai","year":"2023","unstructured":"Kai M, Vion PA, Boussouar S, Cacoub P, Saadoun D, Le Joncour A. Eosinophilic granulomatosis polyangiitis (EGPA) complicated with periaortitis, precipitating role of dupilumab? A case report a review of the literature. RMD Open. 2023;9(3):e003300.","journal-title":"RMD Open"},{"issue":"8","key":"1914_CR68","first-page":"e27670","volume":"14","author":"P Persaud","year":"2022","unstructured":"Persaud P, Karmali R, Sankar P, Majid M. Dupilumab-Associated eosinophilic granulomatosis with polyangiitis. Cureus. 2022;14(8):e27670.","journal-title":"Cureus"},{"issue":"3","key":"1914_CR69","doi-asserted-by":"publisher","first-page":"103503","DOI":"10.1016\/j.autrev.2023.103503","volume":"23","author":"F Davanzo","year":"2024","unstructured":"Davanzo F, Marchi MR, Iorio L, Bortoli M, Doria A, Padoan R. Combination of monoclonal antibodies targeting type 2 inflammation for severe asthma and eosinophilic granulomatosis with polyangiitis. Autoimmun Rev. 2024;23(3):103503.","journal-title":"Autoimmun Rev"}],"container-title":["Journal of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-025-01914-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10875-025-01914-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-025-01914-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T17:02:15Z","timestamp":1777309335000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10875-025-01914-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,24]]},"references-count":69,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["1914"],"URL":"https:\/\/doi.org\/10.1007\/s10875-025-01914-x","relation":{},"ISSN":["0271-9142","1573-2592"],"issn-type":[{"value":"0271-9142","type":"print"},{"value":"1573-2592","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,24]]},"assertion":[{"value":"17 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author Disclosure Statement"}},{"value":"This manuscript has obtained the informed consent of the patient, and the patient agrees to publish all images, clinical data and other data contained in the manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"114"}}